C.-M. Park et al. / Bioorg. Med. Chem. Lett. 15 (2005) 771–775
775
A.; Hu, Y.; Inohara, N. Oncogene 1998, 17, 3237; (c)
LaCasse, E. C.; Baird, S.; Korneluk, R. G.; MacKenzie,
A. E. Oncogene 1998, 17, 3247.
21. Yang, L.; Mashima, T.; Sato, S.; Mochizuki, M.; Saka-
moto, H.; Yamori, T.; Oh-Hara, T.; Tsuruo, T. Cancer
Res. 2003, 15, 831.
3. Deveraux, Q. L.; Reed, J. C. Gene Dev. 1999, 13, 239.
4. Tamm, I.; Kornblau, S. M.; Segall, H.; Krajewski, S.;
Welsh, K.; Kitada, S.; Scudiero, D. A.; Tudor, G.; Qui, Y.
H.; Monks, A.; Andreeff, M.; Reed, J. C. Clin. Cancer Res.
2000, 6, 1796.
5. Krajewska, W.; Krajewska, S.; Banares, S.; Huang, X.;
Turner, B.; Bubendorf, L.; Kallioniemi, O. P.; Shabaik,
A.; Vitiello, A.; Peehl, D.; Gao, G. J.; Reed, J. C. Clin.
Cancer Res. 2003, 9, 4914.
6. Deveraux, Q. L.; Takahashi, R.; Salvesen, G. S.; Reed, J.
C. Nature 1997, 388, 300.
7. Takahashi, R.; Deveraux, Q.; Tamm, I.; Welsh, K.; Assa-
Munt, N.; Salvesen, G. S.; Reed, J. C. J. Biol. Chem. 1998,
273, 7787.
22. Fulda, S.; Wick, W.; Weller, M.; Debatin, K.-M. Nat.
Med. 2002, 8, 808.
23. Wu, T. Y. H.; Wagner, K. W.; Bursulaya, B.; Schultz, P.
G.; Deveraux, Q. L. Chem. Biol. 2003, 10, 759.
24. Nikolovska-Coleska, Z.; Xu, L.; Hu, Z.; Tomita, Y.; Li,
P.; Roller, P. P.; Wang, R.; Fang, X.; Guo, R.; Zhang, M.;
Lippman, M. E.; Yang, D.; Wang, S. J. Med. Chem. 2004,
47, 2430.
25. Schimmer, A. D.; Welsh, K.; Pinilla, C.; Wang, Z.;
Krajewska, M.; Bonneau, M.-J.; Pedersen, I. M.
Kitada, S.; Scott, F. L.; Bailly-Maitre, B.; Glinsky, G.;
Scudiero, D.; Sausville, E.; Salvesen, G.; Nefzi, A.;
Ostresh, J. M.; Houghten, R. A.; Reed, J. C. Cancer Cell
2004, 5, 25.
8. Suzuki, Y.; Nakabayahi, Y.; Nakata, K.; Reed, J. C.;
Takahashi, R. J. Biol. Chem. 2001, 276, 27058.
9. Sun, C.; Cai, M.; Meadows, R. P.; Xu, N.; Gunasekera, A.
H.; Herrmann, J.; Wu, J. C.; Fesik, S. W. J. Biol. Chem.
2000, 275, 33777.
10. Srinivasula, S. M.; Hegde, R.; Saleh, A.; Datta, P.;
Shiozaki, E.; Chai, J.; Lee, R.-A.; Robbins, P. D.;
Fernandes-Alnemri, T.; Shi, Y.; Alnemri, E. S. Nature
2001, 410, 112.
11. Shiozaki, E. N.; Chai, J.; Rigotti, D. J.; Riedl, S. J.; Li, P.;
Srinivasula, S. M.; Alnemri, E. S.; Fairman, R.; Shi, Y.
Mol. Cell. 2003, 11, 519.
12. Chai, J.; Du, C.; Wu, J.-W.; Kyin, S.; Wang, X.; Shi, Y.
Nature 2000, 406, 855.
26. Sun, H.; Nikolovska-Coleska, Z.; Yang, C.; Xu, L.;
Tomita, Y.; Krajewski, K.; Roller, P. P.; Wang, S. J.
Med. Chem. 2004, 47, 4147.
27. Fincham, C. I.; Higginbottom, M.; Hill, D. R.; Horwell,
D. C.; OÕToole, J. C.; Ratcliffe, G. S.; Rees, D. C.;
Roberts, E. J. Med. Chem. 1992, 35, 1472.
28. Huff, J. R.; Baldwin, J. J.; Solms, S. J.; Guare, J. P.; Hunt,
C. A. J. Med. Chem. 1988, 31, 641.
29. Chambers, R. R.; Collins, C. J.; Maxwell, B. E. J. Org.
Chem. 1985, 50, 4960.
30. Maggiotti, V.; Wong, J.-B.; Razet, R.; Cowley, A. R.;
Gouverneur, V. Tetrahedron: Asymmetry 2002, 13, 1789.
31. Expression and purification of BIR3 protein: The BIR3
protein was prepared as described.13,18 NMR samples
2
13. Liu, Z.; Sun, C.; Olejniczak, E. T.; Meadows, R. P.; Betz,
S. F.; Oost, T.; Herrmann, J.; Wu, J. C.; Fesik, S. W.
Nature 2000, 408, 1004.
contained 0.8mM protein in either 90% H2O/10% H2O,
or 100% 2H2O, 10mM phosphate at (pH7.2), 150mM
NaCl, and 1mM H-dithiothreitol.
2
14. Wu, G.; Chai, J.; Suber, T. L.; Wu, J.-W.; Du, C.; Wang,
X.; Shi, Y. Nature 2000, 408, 1008.
15. Kipp, R. A.; Case, M. A.; Wist, A. D.; Cresson, C. M.;
Carrell, M.; Griner, E.; Wiita, A.; Albiniak, P. A.; Chai,
J.; Shi, Y.; Semmelhack, M. F.; McLendon, G. L.
Biochemistry 2002, 41, 7344.
16. Tamm, I.; Trepel, M.; Cardo-Vila, M.; Sun, Y.; Welsh, K.;
Cabezas, E.; Swatterthwait, A.; Arap, W.; Reed, J. C.;
Pasqualini, R. J. Biol. Chem. 2003, 278, 14401.
17. Franklin, M. C.; Kadkhodayan, S.; Ackerly, H.;
Alexandru, D.; Distefano, M. D.; Elliott, L. O.; Flygare,
J. A.; Mausisa, G.; Okawa, D. C.; Ong, D.; Vucic, D.;
Deshayes, K.; Fairbrother, W. J. Biochemistry 2003, 42,
8223.
32. NMR spectroscopy: All NMR experiments were acquired
at 303K on a Bruker DRX600 NMR spectrometer.
Resonances were assigned using both NOESY and HCCH
TOCSY experiments. NOE distance restraints were
obtained from three-dimensional 13C-edited NOESY and
13C-edited filtered NOESY spectra acquired with a mixing
time of 80ms.
33. Structure calculations: BIR3/Ligand structures were cal-
culated using a docking protocol implemented with the
program Xplor-NIH. Ligands were docked into the
previously determined BIR3/SMAC average structure
followed by energy minimization to optimize the confor-
mation of the complex. Fifteen inter-molecular NOEs
were obtained for docking ligand 20g.
18. Oost, T. K.; Sun, C.; Armstrong, R. C.; Al-Assaad, A.-S.;
Betz, S. F.; Deckwerth, T. L.; Ding, H.; Elmore, S. W.;
Meadows, R. P.; Olejniczak, E. T.; Oleksijew, A.; Olters-
dorf, T.; Rosenberg, S. H.; Shoemaker, A. R.; Tomaselli,
K. J.; Zou, H.; Fesik, S. W. J. Med. Chem. 2004, ASAP.
19. Arnt, C. R.; Chiorean, M. V.; Heldebrant, M. P.; Gores,
G. J.; Kaufmann, S. H. J. Biol. Chem. 2002, 277,
44236.
34. Ligand binding: A fluorescence polarization anisotropy
(FPA) competition assay was used to determine the
affinities of compounds to BIR3 protein. Fluorescence
polarization measurements were carried out on an Analyst
96-well plate reader (LJL, Molecular Dynamic, Sunny-
vale, CA). 6-Carboxyfluorescein (FAM) labeled peptides
with the sequences AVPIAQK(FAM)-NH2 was used as
probes. Dissociation constants were determined from
titration curves with in-house written software using the
analytical expressions of Wang.35
20. Guo, F.; Nimmanapalli, R.; Paranawithana, S.; Wittman,
S.; Griffin, D.; Bali, P.; OÕBryan, E.; Fumero, C.; Wang,
H. G.; Bhalla, K. Blood 2002, 99, 3419.
35. Wang, Z.-X. FEBS Lett. 1995, 360, 111.